324 related articles for article (PubMed ID: 15227640)
1. Length of the antibody heavy chain complementarity determining region 3 as a specificity-determining factor.
Barrios Y; Jirholt P; Ohlin M
J Mol Recognit; 2004; 17(4):332-8. PubMed ID: 15227640
[TBL] [Abstract][Full Text] [Related]
2. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.
Giles I; Lambrianides N; Latchman D; Chen P; Chukwuocha R; Isenberg D; Rahman A
Arthritis Res Ther; 2005; 7(1):R47-56. PubMed ID: 15642142
[TBL] [Abstract][Full Text] [Related]
3. Phage-displayed antibody libraries of synthetic heavy chain complementarity determining regions.
Sidhu SS; Li B; Chen Y; Fellouse FA; Eigenbrot C; Fuh G
J Mol Biol; 2004 Apr; 338(2):299-310. PubMed ID: 15066433
[TBL] [Abstract][Full Text] [Related]
4. Display of somatostatin-related peptides in the complementarity determining regions of an antibody light chain.
Simon PJ; Brogle KC; Wang B; Kyle DJ; Soltis DA
Arch Biochem Biophys; 2005 Aug; 440(2):148-57. PubMed ID: 16051181
[TBL] [Abstract][Full Text] [Related]
5. A structure-based database of antibody variable domain diversity.
Bond CJ; Wiesmann C; Marsters JC; Sidhu SS
J Mol Biol; 2005 May; 348(3):699-709. PubMed ID: 15826665
[TBL] [Abstract][Full Text] [Related]
6. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies.
Rothe C; Urlinger S; Löhning C; Prassler J; Stark Y; Jäger U; Hubner B; Bardroff M; Pradel I; Boss M; Bittlingmaier R; Bataa T; Frisch C; Brocks B; Honegger A; Urban M
J Mol Biol; 2008 Feb; 376(4):1182-200. PubMed ID: 18191144
[TBL] [Abstract][Full Text] [Related]
7. High-throughput generation of synthetic antibodies from highly functional minimalist phage-displayed libraries.
Fellouse FA; Esaki K; Birtalan S; Raptis D; Cancasci VJ; Koide A; Jhurani P; Vasser M; Wiesmann C; Kossiakoff AA; Koide S; Sidhu SS
J Mol Biol; 2007 Nov; 373(4):924-40. PubMed ID: 17825836
[TBL] [Abstract][Full Text] [Related]
8. Structural classification of CDR-H3 revisited: a lesson in antibody modeling.
Kuroda D; Shirai H; Kobori M; Nakamura H
Proteins; 2008 Nov; 73(3):608-20. PubMed ID: 18473362
[TBL] [Abstract][Full Text] [Related]
9. Systematic classification of CDR-L3 in antibodies: implications of the light chain subtypes and the VL-VH interface.
Kuroda D; Shirai H; Kobori M; Nakamura H
Proteins; 2009 Apr; 75(1):139-46. PubMed ID: 18798566
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a high-affinity human antibody with a disulfide bridge in the third complementarity-determining region of the heavy chain.
Almagro JC; Raghunathan G; Beil E; Janecki DJ; Chen Q; Dinh T; LaCombe A; Connor J; Ware M; Kim PH; Swanson RV; Fransson J
J Mol Recognit; 2012 Mar; 25(3):125-35. PubMed ID: 22407976
[TBL] [Abstract][Full Text] [Related]
11. A semi-synthetic repertoire of intrinsically stable antibody fragments derived from a single-framework scaffold.
Desiderio A; Franconi R; Lopez M; Villani ME; Viti F; Chiaraluce R; Consalvi V; Neri D; Benvenuto E
J Mol Biol; 2001 Jul; 310(3):603-15. PubMed ID: 11439027
[TBL] [Abstract][Full Text] [Related]
12. Energy-based analysis and prediction of the orientation between light- and heavy-chain antibody variable domains.
Narayanan A; Sellers BD; Jacobson MP
J Mol Biol; 2009 May; 388(5):941-53. PubMed ID: 19324053
[TBL] [Abstract][Full Text] [Related]
13. Engineering a high-affinity anti-IL-15 antibody: crystal structure reveals an α-helix in VH CDR3 as key component of paratope.
Lowe DC; Gerhardt S; Ward A; Hargreaves D; Anderson M; Ferraro F; Pauptit RA; Pattison DV; Buchanan C; Popovic B; Finch DK; Wilkinson T; Sleeman M; Vaughan TJ; Mallinder PR
J Mol Biol; 2011 Feb; 406(1):160-75. PubMed ID: 21167836
[TBL] [Abstract][Full Text] [Related]
14. Shark IgNAR antibody mimotopes target a murine immunoglobulin through extended CDR3 loop structures.
Simmons DP; Streltsov VA; Dolezal O; Hudson PJ; Coley AM; Foley M; Proll DF; Nuttall SD
Proteins; 2008 Apr; 71(1):119-30. PubMed ID: 17932913
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the horse V(H) repertoire and comparison with the human IGHV germline genes, and sheep, cattle and pig V(H) sequences.
Almagro JC; Martinez L; Smith SL; Alagon A; Estevez J; Paniagua J
Mol Immunol; 2006 Apr; 43(11):1836-45. PubMed ID: 16337682
[TBL] [Abstract][Full Text] [Related]
16. Automated classification of antibody complementarity determining region 3 of the heavy chain (H3) loops into canonical forms and its application to protein structure prediction.
Oliva B; Bates PA; Querol E; Avilés FX; Sternberg MJ
J Mol Biol; 1998 Jun; 279(5):1193-210. PubMed ID: 9642095
[TBL] [Abstract][Full Text] [Related]
17. Affinity maturation of a humanized rat antibody for anti-RAGE therapy: comprehensive mutagenesis reveals a high level of mutational plasticity both inside and outside the complementarity-determining regions.
Finlay WJ; Cunningham O; Lambert MA; Darmanin-Sheehan A; Liu X; Fennell BJ; Mahon CM; Cummins E; Wade JM; O'Sullivan CM; Tan XY; Piche N; Pittman DD; Paulsen J; Tchistiakova L; Kodangattil S; Gill D; Hufton SE
J Mol Biol; 2009 May; 388(3):541-58. PubMed ID: 19285987
[TBL] [Abstract][Full Text] [Related]
18. Comment on "Engineering antibody heavy chain CDR3 to create a phage display Fab library rich in antibodies that bind charged carbohydrates".
Lucas AH; Reason DC
J Immunol; 2009 May; 182(9):5160-1. PubMed ID: 19380755
[No Abstract] [Full Text] [Related]
19. Evidence for structural plasticity of heavy chain complementarity-determining region 3 in antibody-ssDNA recognition.
Schuermann JP; Prewitt SP; Davies C; Deutscher SL; Tanner JJ
J Mol Biol; 2005 Apr; 347(5):965-78. PubMed ID: 15784256
[TBL] [Abstract][Full Text] [Related]
20. Rheumatoid factor specificity of a VH3-encoded antibody is dependent on the heavy chain CDR3 region and is independent of protein A binding.
Zhang M; Majid A; Bardwell P; Vee C; Davidson A
J Immunol; 1998 Sep; 161(5):2284-9. PubMed ID: 9725222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
